Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122684524 | 12268452 | 4 | F | 20160321 | 20160721 | 20160414 | 20160729 | EXP | GB-MYLANLABS-2016M1014514 | MYLAN | 0.00 | Y | 0.00000 | 20160729 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122684524 | 12268452 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 156 MG, UNK | U | U | 91062 | 156 | MG | ||||||
122684524 | 12268452 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | 156 UNK, UNK | U | U | 91062 | 156 | MG | |||||||
122684524 | 12268452 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 675 MG, UNK | U | U | 0 | 675 | MG | ||||||
122684524 | 12268452 | 4 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 675 MG, UNK | U | U | 0 | 675 | MG | ||||||
122684524 | 12268452 | 5 | SS | DENOSUMAB | DENOSUMAB | 1 | Unknown | 120 MG, UNK | U | U | 0 | 120 | MG | ||||||
122684524 | 12268452 | 6 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | U | U | 0 | 6 | MG | ||||||
122684524 | 12268452 | 7 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | U | U | 0 | 6 | MG | ||||||
122684524 | 12268452 | 8 | SS | PEMETREXED | PEMETREXED | 1 | Unknown | 1050 MG, UNK | U | U | 0 | 1050 | MG | ||||||
122684524 | 12268452 | 9 | SS | PEMETREXED | PEMETREXED | 1 | 1050 MG, UNK | U | U | 0 | 1050 | MG | |||||||
122684524 | 12268452 | 10 | SS | APREPITANT. | APREPITANT | 1 | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122684524 | 12268452 | 1 | Product used for unknown indication |
122684524 | 12268452 | 3 | Product used for unknown indication |
122684524 | 12268452 | 5 | Product used for unknown indication |
122684524 | 12268452 | 6 | Product used for unknown indication |
122684524 | 12268452 | 8 | Product used for unknown indication |
122684524 | 12268452 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122684524 | 12268452 | OT |
122684524 | 12268452 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122684524 | 12268452 | Alopecia | |
122684524 | 12268452 | Contusion | |
122684524 | 12268452 | Cough | |
122684524 | 12268452 | Decreased appetite | |
122684524 | 12268452 | Dehydration | |
122684524 | 12268452 | Dizziness | |
122684524 | 12268452 | Dysgeusia | |
122684524 | 12268452 | Dyspnoea | |
122684524 | 12268452 | Epistaxis | |
122684524 | 12268452 | Fall | |
122684524 | 12268452 | Fatigue | |
122684524 | 12268452 | Flushing | |
122684524 | 12268452 | Headache | |
122684524 | 12268452 | Joint swelling | |
122684524 | 12268452 | Malaise | |
122684524 | 12268452 | Melaena | |
122684524 | 12268452 | Neuropathy peripheral | |
122684524 | 12268452 | Ocular hyperaemia | |
122684524 | 12268452 | Paraesthesia | |
122684524 | 12268452 | Rhinorrhoea | |
122684524 | 12268452 | Somnolence | |
122684524 | 12268452 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122684524 | 12268452 | 2 | 20160321 | 0 | ||
122684524 | 12268452 | 3 | 20160321 | 0 | ||
122684524 | 12268452 | 6 | 20160322 | 0 | ||
122684524 | 12268452 | 7 | 20160322 | 0 | ||
122684524 | 12268452 | 8 | 20160321 | 0 | ||
122684524 | 12268452 | 9 | 20160321 | 0 |